29/01/2026
Central Council for Research in Homeopathy (CCRH) and Indian Council for Medical Research (ICMR) sign an MoU to undertake a joint research on effects of Homeopathic medicines on some forms of cancer cells. Can this be possible in our country?
Central Council for Research in Homoeopathy (CCRH), Ministry of Ayush, Government of India, and Indian Council of Medical Researchโ National Institute of Cancer Prevention and Research (ICMR-NICPR) have signed a Memorandum of Understanding to undertake joint research for the research study titled 'Comprehensive Transcriptomic & Epigenomic Assessment of Homeopathic Preparation of Hydrastis & Condurango Homeopathy Drugs in Lung Cancer Cell Lines & Animal Model System'. This study aims to explore the molecular mechanism of homeopathic medicines and their anticancer effects In-vitro and in-vivo.
The MoU was signed between Dr. Subhash Kaushik, Director General, CCRH, and Dr. Shalini Singh, Director, ICMR-NICPR in the presence of the Principal Investigator, Dr R. Suresh Kumar, Scientist-F, ICMR-NICPR on 23rd January 2026.
Dr. K.C. Muraleedharan, Assistant Director (H)/Scientist-4, CCRH, Dr. Manas R Sarangi, Research Officer (H)/Scientist-3, CCRH, Dr. Pramod Kumar, Scientist-D, ICMR-NICPR, who are part of the study team and other scientists from ICMR-NICPR were also present.
Dr. Manas R Sarangi, Research Officer (H)/Scientist-3, CCRH Co-ordinator and Investigator of the study coordinated the signing of the MoU.
MyGovIndia Press Information Bureau - PIB, Government of India